All Stories

  1. Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates

    Article • Vaccines, June 2026, MDPI AG

    Professor Nikolai Petrovsky

  2. Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy

    Article • Journal of Inflammation Research, May 2026, Taylor & Francis

    Professor Nikolai Petrovsky

  3. Design and Synthesis of New Pyrazolo[1,5‐ c ]quinazolin‐5‐amines as Potential TLR7/8 Modulators

    Article • ChemMedChem, April 2026, Wiley

    Professor Nikolai Petrovsky

  4. Safety of an adjuvanted thermostable dry powder live attenuated influenza vaccine in ferrets

    Article • January 2026, Elsevier

    Professor Nikolai Petrovsky

  5. SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody

    Article • Antiviral Research, September 2025, Elsevier

    Professor Nikolai Petrovsky

  6. Advax delta inulin adjuvant accelerates humoral anti-influenza response

    Article • Immunology and Cell Biology, July 2025, Wiley

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  7. Delta inulin alone or combined with CpG oligonucleotide enhances antibody‐dependent influenza vaccine protection in mice and nonhuman primate newborns

    Article • Immunology and Cell Biology, June 2025, Wiley

    Professor Nikolai Petrovsky

  8. One Health adjuvant selection for vaccines against zoonotic infections

    Article • Exploration of Medicine, May 2025, Open Exploration Publishing

    Professor Nikolai Petrovsky

  9. Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human Primates

    Article • February 2025, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  10. Virus-like particle-based vaccines targeting theAnophelesmosquito salivary protein, TRIO

    Article • September 2024, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  11. Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant

    Article • International Journal of Molecular Sciences, August 2024, MDPI AG

    Professor Nikolai Petrovsky

  12. MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity

    Article • Pathogens, June 2024, MDPI AG

    Professor Nikolai Petrovsky

  13. Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine

    Article • Human Vaccines & Immunotherapeutics, June 2024, Taylor & Francis

    Professor Nikolai Petrovsky

  14. Dendritic cell–specific intercellular adhesion molecule‐3‐grabbing nonintegrin (DC‐SIGN) is a cellular receptor for delta inulin adjuvant

    Article • Immunology and Cell Biology, May 2024, Wiley

    Professor Nikolai Petrovsky

  15. Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist

    Article • Journal of Medicinal Chemistry, May 2024, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  16. Structure-activity relationship in NOD2 agonistic muramyl dipeptides

    Article • European Journal of Medicinal Chemistry, May 2024, Elsevier

    Professor Nikolai Petrovsky

  17. Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines

    Article • Vaccines, April 2024, MDPI AG

    Professor Nikolai Petrovsky

  18. Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates

    Article • Vaccines, April 2024, MDPI AG

    Professor Nikolai Petrovsky

  19. Structure−Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist

    Article • February 2024, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  20. Safety and immunogenicity of an adjuvanted recombinant spike protein‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine, SpikeVet™, in selected Carnivora, Primates and Artiodactyla in Australian zoos

    Article • Journal of Veterinary Pharmacology and Therapeutics, February 2024, Wiley

    Professor Nikolai Petrovsky

  21. Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates

    Article • Vaccine, February 2024, Elsevier

    Professor Nikolai Petrovsky

  22. Lung IL-17A-Producing CD4+ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines

    Article • Vaccines, January 2024, MDPI AG

    Professor Nikolai Petrovsky

  23. Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial

    Article • International Immunopharmacology, January 2024, Elsevier

    Professor Nikolai Petrovsky

  24. Simplified Scalable Synthesis of a Water-Soluble Toll-Like Receptor 2 Agonistic Lipopeptide Adjuvant for Use with Protein-Based Viral Vaccines

    Article • January 2024, Elsevier

    Professor Nikolai Petrovsky

  25. A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age

    Article • The Journal of Infectious Diseases, December 2023, Oxford University Press (OUP)

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  26. Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants

    Article • Vaccine, November 2023, Elsevier

    Professor Nikolai Petrovsky

  27. Structure-Activity Relationship in NOD2 Agonistic Muramyl Dipeptides

    Article • September 2023, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  28. An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection

    Article • Vaccine, September 2023, Elsevier

    Professor Nikolai Petrovsky

  29. Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice

    Article • Vaccine, September 2023, Elsevier

    Professor Nikolai Petrovsky

  30. An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice

    Article • Vaccine, August 2023, Elsevier

    Professor Nikolai Petrovsky

  31. Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters

    Article • Scientific Reports, August 2023, Springer Science + Business Media

    Professor Nikolai Petrovsky

  32. Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques

    Article • Human Vaccines & Immunotherapeutics, August 2023, Taylor & Francis

    Professor Nikolai Petrovsky

  33. An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters

    Article • Scientific Reports, July 2023, Springer Science + Business Media

    Professor Nikolai Petrovsky

  34. Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates

    Article • Vaccines, July 2023, MDPI AG

    Professor Nikolai Petrovsky

  35. An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge

    Article • Vaccine, July 2023, Elsevier

    Professor Nikolai Petrovsky

  36. Detection, characterization, and persistence of Campylobacter hepaticus, the cause of spotty liver disease in layer hens

    Article • Poultry Science, July 2023, Elsevier

    Professor Nikolai Petrovsky

  37. Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants

    Article • Immunology, May 2023, Wiley

    Professor Nikolai Petrovsky

  38. Lignin nanoparticles as a novel carrier for efficacious delivery of toll like receptor 7/8 agonist: Physicochemical and in-vitro evaluation

    Article • Journal of the Indian Chemical Society, May 2023, Elsevier

    Professor Nikolai Petrovsky

  39. Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  40. An alternative protein-based vaccine against COVID-19

    Article • Clinical Microbiology and Infection, February 2023, Elsevier

    Professor Nikolai Petrovsky

  41. A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice

    Article • Frontiers in Immunology, November 2022, Frontiers

    Professor Kaissar Tabynov, Professor Nikolai Petrovsky

  42. Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2

    Article • Mucosal Immunology, November 2022, Elsevier

    Professor Nikolai Petrovsky

  43. Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

    Article • npj Vaccines, October 2022, Springer Science + Business Media

    Professor Nikolai Petrovsky

  44. Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation

    Article • Frontiers in Immunology, October 2022, Frontiers

    Professor Nikolai Petrovsky

  45. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics

    Article • Current Opinion in Chemical Biology, October 2022, Elsevier

    Professor Nikolai Petrovsky

  46. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

    Article • Expert Opinion on Drug Safety, September 2022, Taylor & Francis

    Professor Nikolai Petrovsky

  47. Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

    Article • Clinical Microbiology and Infection, September 2022, Elsevier

    Professor Nikolai Petrovsky

  48. Narrative Review: Obesity, Type 2 DM and Obstructive Sleep Apnoea—Common Bedfellows

    Article • Diabetology, August 2022, MDPI AG

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  49. Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial

    Article • Immunology, July 2022, Wiley

    Professor Nikolai Petrovsky

  50. Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  51. A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates

    Article • Vaccine, July 2022, Elsevier

    Professor Nikolai Petrovsky

  52. Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis

    Article • Vaccines, May 2022, MDPI AG

    Professor Nikolai Petrovsky

  53. Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice

    Article • Microorganisms, May 2022, MDPI AG

    Professor Nikolai Petrovsky

  54. Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters

    Article • Vaccine, May 2022, Elsevier

    Professor Nikolai Petrovsky

  55. Identification of adjuvants for γδ T cells in response to a novel M. tuberculosis vaccine antigen

    Article • The Journal of Immunology, May 2022, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  56. Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255

    Article • Microorganisms, March 2022, MDPI AG

    Professor Nikolai Petrovsky

  57. Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model

    Article • Frontiers in Immunology, March 2022, Frontiers

    Professor Kaissar Tabynov, Professor Nikolai Petrovsky

  58. Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies

    Article • Frontiers in Molecular Biosciences, March 2022, Frontiers

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  59. A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats

    Article • Frontiers in Veterinary Science, March 2022, Frontiers

    Professor Kaissar Tabynov, Professor Nikolai Petrovsky

  60. A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model

    Article • npj Vaccines, March 2022, Springer Science + Business Media

    Professor Nikolai Petrovsky

  61. Potential COVID-19 therapies from computational repurposing of drugs and natural products against the SARS-CoV-2 helicase

    Article • March 2022, American Chemical Society (ACS)

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  62. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

    Article • npj Vaccines, February 2022, Springer Science + Business Media

    Professor Kaissar Tabynov, Professor Nikolai Petrovsky

  63. Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice

    Article • International Journal of Pharmaceutics, February 2022, Elsevier

    Professor Nikolai Petrovsky

  64. Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants

    Article • RSC Medicinal Chemistry, January 2022, Royal Society of Chemistry

    Professor Nikolai Petrovsky

  65. Artificial Intelligence in Vaccine and Drug Design

    Article • December 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  66. Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates

    Article • Vaccine, December 2021, Elsevier

    Professor Nikolai Petrovsky

  67. A Spike protein-based subunit SARS-CoV-2 vaccine for pets: safety, immunogenicity, and protective efficacy in juvenile cats

    Article • November 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  68. A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  69. An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

    Article • Vaccines, October 2021, MDPI AG

    Professor Nikolai Petrovsky

  70. Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective

    Article • Bioanalysis, October 2021, Taylor & Francis

    Professor Nikolai Petrovsky

  71. An Advax-adjuvanted Inactivated Cell-culture Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-flavivirus Antibodies and T-cell Immunity and Provides Single Dose Protection

    Article • October 2021, MDPI AG

    Professor Nikolai Petrovsky

  72. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  73. An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2

    Article • The Lancet, October 2021, Elsevier

    Professor Nikolai Petrovsky

  74. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

    Article • September 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  75. Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies

    Article • Molecular Biomedicine, September 2021, Springer Science + Business Media

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  76. Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin

    Article • Scientific Reports, September 2021, Springer Science + Business Media

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  77. Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent

    Article • Journal of Pharmacy and Pharmacology, September 2021, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  78. A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection

    Article • Vaccine, September 2021, Elsevier

    Professor Nikolai Petrovsky

  79. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

    Article • Vaccine, September 2021, Elsevier

    Professor Nikolai Petrovsky

  80. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection

    Article • mBio, August 2021, ASM Journals

    Professor Nikolai Petrovsky

  81. A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization

    Article • Vaccine, August 2021, Elsevier

    Professor Nikolai Petrovsky

  82. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  83. Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment

    Article • AJP Cell Physiology, July 2021, American Physiological Society

    Eunús S. Ali, Ph.D., Professor Nikolai Petrovsky

  84. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin

    Article • Scientific Reports, June 2021, Springer Science + Business Media

    Professor Dave A Winkler, Professor Nikolai Petrovsky

  85. Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice

    Article • Pathogens, May 2021, MDPI AG

    Professor Nikolai Petrovsky

  86. Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction

    Article • Mucosal Immunology, May 2021, Elsevier

    Professor Nikolai Petrovsky

  87. Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines

    Article • Pathogens, April 2021, MDPI AG

    Professor Nikolai Petrovsky

  88. Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets

    Article • npj Vaccines, April 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  89. Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity

    Article • Vaccine, April 2021, Elsevier

    Professor Nikolai Petrovsky

  90. Combination adjuvants enhance recombinant protein vaccine protection against fungal infection

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  91. Accelerated vaccine induction of IgM neutralising antibody enables vaccine protection against same day lethal influenza virus challenge

    Article • February 2021, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  92. Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice

    Article • npj Vaccines, January 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  93. An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein

    Article • npj Vaccines, January 2021, Springer Science + Business Media

    Professor Nikolai Petrovsky

  94. Strategies for active and passive pediatric RSV immunization

    Article • Therapeutic Advances in Vaccines and Immunotherapy, January 2021, SAGE Publications

    Professor Nikolai Petrovsky

  95. Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles

    Article • RSC Medicinal Chemistry, January 2021, Royal Society of Chemistry

    Professor Nikolai Petrovsky

  96. TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects

    Article • Journal of Medicinal Chemistry, December 2020, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  97. Developing Translational Vaccines against Heroin and Fentanyl through Investigation of Adjuvants and Stability

    Article • Molecular Pharmaceutics, December 2020, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  98. Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis

    Article • npj Vaccines, November 2020, Springer Science + Business Media

    Professor Nikolai Petrovsky

  99. Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity

    Article • Vaccine, November 2020, Elsevier

    Professor Nikolai Petrovsky

  100. Advax adjuvant formulations promote protective immunity against aerosolMycobacterium tuberculosisin the absence of deleterious inflammation and reactogenicity

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  101. Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance

    Article • Diabetes, September 2020, American Diabetes Association

    Professor Nikolai Petrovsky

  102. Flavivirus DNA Vaccine Design and Adjuvant Selection

    Article • September 2020, Springer Science + Business Media

    Professor Nikolai Petrovsky

  103. An Epitope-based Malaria Vaccine Targeting the Junctional Domain of Circumsporozoite Protein

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  104. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection

    Article • Frontiers in Immunology, July 2020, Frontiers

    Professor Nikolai Petrovsky

  105. Adjuvant selection impacts the correlates of vaccine protection against Ebola infection

    Article • Vaccine, June 2020, Elsevier

    Professor Nikolai Petrovsky

  106. Influence of Oxidation Degree on the Physicochemical Properties of Oxidized Inulin

    Article • Polymers, May 2020, MDPI AG

    Professor Nikolai Petrovsky

  107. Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies

    Article • mBio, April 2020, ASM Journals

    Professor Nikolai Petrovsky

  108. BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant

    Article • Human Vaccines & Immunotherapeutics, April 2020, Taylor & Francis

    Professor Nikolai Petrovsky

  109. Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependant protection against pulmonary tuberculosis

    Article • February 2020, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  110. Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

    Article • Neurobiology of Disease, February 2020, Elsevier

    Professor Nikolai Petrovsky

  111. Prediction of novel mouse TLR9 agonists using a random forest approach

    Article • BMC Molecular and Cell Biology, December 2019, Springer Science + Business Media

    Professor Nikolai Petrovsky

  112. Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

    Article • Alzheimer s Research & Therapy, December 2019, Springer Science + Business Media

    Professor Nikolai Petrovsky

  113. Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation

    Article • Pharmaceutics, November 2019, MDPI AG

    Professor Nikolai Petrovsky

  114. A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

    Article • Scientific Reports, October 2019, Springer Science + Business Media

    Professor Nikolai Petrovsky

  115. Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery

    Article • Pharmaceutics, October 2019, MDPI AG

    Professor Nikolai Petrovsky

  116. Review of polysaccharide particle-based functional drug delivery

    Article • Carbohydrate Polymers, October 2019, Elsevier

    Professor Nikolai Petrovsky

  117. MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus

    Article • Investigative Ophthalmology & Visual Science, September 2019, Association for Research in Vision and Ophthalmology (ARVO)

    Professor Nikolai Petrovsky, Professor Jonathan M Gleadle

  118. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity

    Article • Microorganisms, August 2019, MDPI AG

    Professor Nikolai Petrovsky

  119. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy

    Article • Journal of Pharmaceutical and Biomedical Analysis, August 2019, Elsevier

    Professor Nikolai Petrovsky

  120. Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy

    Article • Journal of Allergy and Clinical Immunology, August 2019, Elsevier

    Professor Nikolai Petrovsky

  121. Use of adjuvants to make neonatal vaccines more effective

    Article • Expert Review of Clinical Immunology, July 2019, Taylor & Francis

    Professor Nikolai Petrovsky

  122. Design and Characterization of Inulin Conjugate for Improved Intracellular and Targeted Delivery of Pyrazinoic Acid to Monocytes

    Article • Pharmaceutics, May 2019, MDPI AG

    Professor Nikolai Petrovsky

  123. Calcium Signaling As a Therapeutic Target for Liver Steatosis

    Article • Trends in Endocrinology and Metabolism, April 2019, Elsevier

    Eunús S. Ali, Ph.D., Professor Nikolai Petrovsky

  124. A Microfluidic Tumor‐on‐a‐Chip for Assessing Multifunctional Liposomes' Tumor Targeting and Anticancer Efficacy

    Article • Advanced Healthcare Materials, March 2019, Wiley

    Professor Nikolai Petrovsky

  125. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

    Article • Viruses, March 2019, MDPI AG

    Professor Nikolai Petrovsky

  126. Microfluidic formation of core-shell alginate microparticles for protein encapsulation and controlled release

    Article • Journal of Colloid and Interface Science, March 2019, Elsevier

    Professor Nikolai Petrovsky

  127. Mitochondrial haplogroups are not associated with diabetic retinopathy in a large Australian and British Caucasian sample

    Article • Scientific Reports, January 2019, Springer Science + Business Media

    Professor Nikolai Petrovsky, Professor Jonathan M Gleadle

  128. Synthesis and characterization of a novel inulin hydrogel crosslinked with pyromellitic dianhydride

    Article • Reactive and Functional Polymers, January 2019, Elsevier

    Professor Nikolai Petrovsky

  129. Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge

    Article • European Journal of Pharmaceutics and Biopharmaceutics, December 2018, Elsevier

    Professor Nikolai Petrovsky

  130. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2018, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt, Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  131. The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients

    Article • Veterinary Sciences, October 2018, MDPI AG

    Professor Nikolai Petrovsky

  132. Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge

    Article • Journal of Controlled Release, October 2018, Elsevier

    Professor Nikolai Petrovsky

  133. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy

    Article • BMC Medical Genetics, May 2018, Springer Science + Business Media

    Professor Nikolai Petrovsky

  134. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats

    Article • PLOS One, October 2017, PLOS

    Professor Kaissar Tabynov, Professor Nikolai Petrovsky

  135. Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures

    Article • Vaccine, October 2017, Elsevier

    Professor Nikolai Petrovsky

  136. Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection

    Article • Human Vaccines & Immunotherapeutics, September 2017, Taylor & Francis

    Professor Ana Paula Junqueira Kipnis, Professor Nikolai Petrovsky, Prof. Dr. Mara Rubia N Celes

  137. Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Professor Nikolai Petrovsky

  138. DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant

    Article • Journal of General Virology, August 2017, Society for General Microbiology

    Professor Nikolai Petrovsky

  139. Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant

    Article • Vaccine, August 2017, Elsevier

    Professor Nikolai Petrovsky

  140. X-ray crystal structure of rivoglitazone bound to PPARγ and PPAR subtype selectivity of TZDs

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, August 2017, Elsevier

    Professor Nikolai Petrovsky

  141. Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology

    Article • Vaccine, July 2017, Elsevier

    Professor Nikolai Petrovsky

  142. Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

    Article • Human Vaccines & Immunotherapeutics, February 2017, Taylor & Francis

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  143. Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines

    Article • EBioMedicine, February 2017, Elsevier

    Professor Nikolai Petrovsky

  144. Molecular Adjuvants for DNA Vaccines

    Article • Current Issues in Molecular Biology, January 2017, MDPI AG

    Professor Nikolai Petrovsky

  145. Vaccine Adjuvant Nanotechnologies

    Article • January 2017, Elsevier

    Professor Nikolai Petrovsky

  146. ALMS1 acts as a critical molecular switch that controls Insulin-stimulated glucose transport in adipocytes

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Professor Nikolai Petrovsky

  147. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens

    Article • Antiviral Research, September 2016, Elsevier

    Eunús S. Ali, Ph.D., Professor Nikolai Petrovsky

  148. Influenza immunization during pregnancy: Benefits for mother and infant

    Article • Human Vaccines & Immunotherapeutics, August 2016, Taylor & Francis

    Professor Nikolai Petrovsky

  149. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice

    Article • PLoS Neglected Tropical Diseases, July 2016, PLOS

    Professor Nikolai Petrovsky

  150. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant

    Article • Vaccine, July 2016, Elsevier

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  151. Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

    Article • Scientific Reports, July 2016, Springer Science + Business Media

    Professor Nikolai Petrovsky

  152. Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation

    Article • Carbohydrate Polymers, June 2016, Elsevier

    Professor Nikolai Petrovsky

  153. Vaxine

    Article • Human Vaccines & Immunotherapeutics, May 2016, Taylor & Francis

    Professor Nikolai Petrovsky

  154. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology

    Article • Human Vaccines & Immunotherapeutics, May 2016, Taylor & Francis

    Professor Nikolai Petrovsky

  155. A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients

    Article • Acta Diabetologica, March 2016, Springer Science + Business Media

    Professor Jonathan M Gleadle, Professor Nikolai Petrovsky

  156. Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes

    Article • Nature Genetics, March 2016, Springer Science + Business Media

    Professor Jane E Dahlstrom, Professor Nikolai Petrovsky

  157. Promoter polymorphism at the tumour necrosis factor/lymphotoxin-alpha locus is associated with type of diabetes but not with susceptibility to sight-threatening diabetic retinopathy

    Article • Diabetes and Vascular Disease Research, January 2016, SAGE Publications

    Professor Nikolai Petrovsky

  158. Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

    Article • January 2016, Springer Science + Business Media

    Professor Nikolai Petrovsky

  159. SARS coronavirus infections of the lower respiratory tract and their prevention

    Article • January 2016, Elsevier

    Professor Nikolai Petrovsky

  160. Molecular mechanisms for enhanced DNA vaccine immunogenicity

    Article • Expert Review of Vaccines, December 2015, Taylor & Francis

    Professor Nikolai Petrovsky

  161. Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety

    Article • Vaccine, November 2015, Elsevier

    Professor Nikolai Petrovsky

  162. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs

    Article • Drug Safety, October 2015, Springer Science + Business Media

    Professor Nikolai Petrovsky

  163. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection

    Article • Vaccine, September 2015, Elsevier

    Professor Nikolai Petrovsky

  164. Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema

    Article • Ophthalmology, September 2015, Elsevier

    Professor Jonathan M Gleadle, Professor Nikolai Petrovsky

  165. Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines

    Article • Journal of Immunological Methods, September 2015, Elsevier

    Professor Nikolai Petrovsky

  166. Novel nanoparticle vaccines for Listeriosis

    Article • Human Vaccines & Immunotherapeutics, August 2015, Taylor & Francis

    Professor Nikolai Petrovsky

  167. Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene

    Article • Diabetologia, July 2015, Springer Science + Business Media

    Professor Nikolai Petrovsky

  168. A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2015, Wiley

    Professor Nikolai Petrovsky

  169. Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine

    Article • PLOS One, July 2015, PLOS

    Dr Dimitar Sajkov, Professor Nikolai Petrovsky

  170. Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: Atomic force microscopy and static molecular modelling

    Article • Carbohydrate Polymers, March 2015, Elsevier

    Professor Nikolai Petrovsky

  171. A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection

    Article • Vaccine, March 2015, Elsevier

    Professor Nikolai Petrovsky

  172. Pulmonary immunisation

    Article • European Journal of Pharmaceutical Sciences, January 2015, Elsevier

    Professor Nikolai Petrovsky

  173. Characterisation of adjuvants for use in dromedary immunisation

    Article • Journal of Camel Practice and Research, January 2015, Diva Enterprises Private Limited

    Professor Nikolai Petrovsky

  174. Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

    Article • Journal of Virology, December 2014, ASM Journals

    Professor Nikolai Petrovsky

  175. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals

    Article • Veterinary Research, December 2014, Springer Science + Business Media

    Professor Nikolai Petrovsky

  176. Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study

    Article • Vaccine, November 2014, Elsevier

    Professor Nikolai Petrovsky

  177. Editorial (Thematic Issue: The Coming of Age of DNA Vaccines)

    Article • Current Gene Therapy, August 2014, Bentham Science Publishers

    Professor Nikolai Petrovsky

  178. Plasmids Encoding Protein Aggregation Domains Act As Molecular Adjuvants for DNA Vaccines

    Article • Current Gene Therapy, August 2014, Bentham Science Publishers

    Professor Nikolai Petrovsky

  179. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection

    Article • Vaccine, August 2014, Elsevier

    Professor Nikolai Petrovsky

  180. In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies

    Article • PLOS One, July 2014, PLOS

    Professor Nikolai Petrovsky

  181. Inulin isoforms differ by repeated additions of one crystal unit cell

    Article • Carbohydrate Polymers, March 2014, Elsevier

    Professor Nikolai Petrovsky

  182. Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant

    Article • Clinical and Vaccine Immunology, February 2014, ASM Journals

    Professor Nikolai Petrovsky

  183. Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity

    Article • Vaccine, January 2014, Elsevier

    Professor Nikolai Petrovsky

  184. Sugar-Based Immune Adjuvants for Use in Recombinant, Viral Vector, DNA and Other Styles of Vaccines

    Article • January 2014, Springer Science + Business Media

    Professor Nikolai Petrovsky

  185. Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics

    Article • Clinical and Experimental Ophthalmology, October 2013, Wiley

    Professor Nikolai Petrovsky

  186. Chiral Self-Assembly of Designed Amphiphiles: Influences on Aggregate Morphology

    Article • Langmuir, July 2013, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  187. An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody

    Article • Journal of Virology, July 2013, ASM Journals

    Professor Nikolai Petrovsky

  188. Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia

    Article • July 2013, IntechOpen

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  189. The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions

    Article • Glycobiology, July 2013, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  190. Vaccine adjuvants: in search of new paradigms

    Article • Expert Review of Vaccines, July 2013, Taylor & Francis

    Professor Nikolai Petrovsky

  191. Vaccine adjuvant safety: the elephant in the room

    Article • Expert Review of Vaccines, July 2013, Taylor & Francis

    Professor Nikolai Petrovsky

  192. A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing

    Article • Vaccine, April 2013, Elsevier

    Professor Nikolai Petrovsky

  193. Flu watch

    Article • The New Scientist, April 2013, Elsevier

    Professor Nikolai Petrovsky

  194. Computational vaccinology and the ICoVax 2012 workshop

    Article • BMC Bioinformatics, March 2013, Springer Science + Business Media

    Professor Nikolai Petrovsky

  195. JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8+ T Cells and Pre-Exposure Neutralizing Antibody

    Article • Journal of Virology, February 2013, ASM Journals

    Professor Nikolai Petrovsky

  196. Systems Immunology, Vaccine Adjuvant

    Article • January 2013, Springer Science + Business Media

    Professor Nikolai Petrovsky

  197. Unconventional Vaccines: Progress and Challenges

    Article • Journal of Vaccines & Vaccination, January 2013, OMICS Publishing Group

    Professor Nikolai Petrovsky

  198. A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle

    Article • Trials in Vaccinology, January 2013, Elsevier

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  199. Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy

    Article • World Allergy Organization Journal, January 2013, Elsevier

    Professor Nikolai Petrovsky

  200. The future of human DNA vaccines

    Article • Journal of Biotechnology, December 2012, Elsevier

    Professor Nikolai Petrovsky

  201. Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses

    Article • Expert Review of Vaccines, December 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  202. BBS-Induced Ciliary Defect Enhances Adipogenesis, Causing Paradoxical Higher-Insulin Sensitivity, Glucose Usage, and Decreased Inflammatory Response

    Article • Cell Metabolism, September 2012, Elsevier

    Professor Nikolai Petrovsky

  203. Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660

    Article • Retrovirology, September 2012, Springer Science + Business Media

    Professor Nikolai Petrovsky

  204. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

    Article • Vaccine, August 2012, Elsevier

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  205. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses

    Article • Vaccine, August 2012, Elsevier

    Professor Nikolai Petrovsky

  206. Report from the field

    Article • Human Vaccines & Immunotherapeutics, July 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  207. Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy

    Article • Carbohydrate Research, May 2012, Elsevier

    Professor Nikolai Petrovsky

  208. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes

    Article • Journal of Diabetes and its Complications, May 2012, Elsevier

    Professor Nikolai Petrovsky

  209. Technologies for enhanced efficacy of DNA vaccines

    Article • Expert Review of Vaccines, February 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  210. Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment

    Article • Diabetes Care, January 2012, American Diabetes Association

    Professor Nikolai Petrovsky

  211. Observation of the keto tautomer of d-fructose in D2O using 1H NMR spectroscopy

    Article • Carbohydrate Research, January 2012, Elsevier

    Professor Nikolai Petrovsky

  212. Dyspnea in Pulmonary Arterial Hypertension

    Article • December 2011, IntechOpen

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  213. Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets

    Article • Vaccine, August 2011, Elsevier

    Professor Nikolai Petrovsky

  214. Effects of perindopril–indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy

    Article • Journal of Hypertension, July 2011, Wolters Kluwer Health

    Professor Nikolai Petrovsky

  215. Pediatric influenza immunization

    Article • Expert Review of Vaccines, May 2011, Taylor & Francis

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  216. Serological responses following influenza A H1N1 2009 infection in adults

    Article • Journal of Infection, May 2011, Elsevier

    Professor Nikolai Petrovsky

  217. Carbohydrate-based immune adjuvants

    Article • Expert Review of Vaccines, April 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  218. The Vaccine Renaissance

    Article • Human Vaccines, February 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  219. Challenges in improving influenza vaccine protection in the elderly

    Article • Expert Review of Vaccines, January 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  220. World Vaccine Congress Asia 2011 (June 20-24, 2011, Singapore)

    Article • Drugs of the Future, January 2011, Prous Science

    Professor Nikolai Petrovsky

  221. Immunome Research-Five Years On

    Article • Immunome Research, January 2011, OMICS Publishing Group

    Professor Nikolai Petrovsky

  222. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

    Article • Journal of General Virology, December 2010, Society for General Microbiology

    Professor Nikolai Petrovsky

  223. Alström syndrome: insights into the pathogenesis of metabolic disorders

    Article • Nature Reviews Endocrinology, December 2010, Springer Science + Business Media

    Professor Nikolai Petrovsky, Dorothee Girard

  224. Delta inulin: a novel, immunologically active, stable packing structure comprising  -D-[2 -> 1] poly(fructo-furanosyl)  -D-glucose polymers

    Article • Glycobiology, December 2010, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  225. Lessons learned from the H1N1 2009 pandemic

    Article • Human Vaccines, October 2010, Taylor & Francis

    Professor Nikolai Petrovsky

  226. Management of dyspnea in advanced pulmonary arterial hypertension

    Article • Current Opinion in Supportive and Palliative Care, June 2010, Wolters Kluwer Health

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  227. Aldose Reductase Gene Polymorphisms and Diabetic Retinopathy Susceptibility

    Article • Diabetes Care, April 2010, American Diabetes Association

    Professor Nikolai Petrovsky

  228. Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus

    Article • Nature Reviews Endocrinology, March 2010, Springer Science + Business Media

    Professor Nikolai Petrovsky

  229. Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes

    Article • PLOS One, March 2010, PLOS

    Professor Nikolai Petrovsky

  230. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

    Article • Journal of General Virology, February 2010, Society for General Microbiology

    Professor Nikolai Petrovsky

  231. Association Between Erythropoietin Gene Polymorphisms and Diabetic Retinopathy

    Article • Archives of Ophthalmology, January 2010, American Medical Association (AMA)

    Professor Nikolai Petrovsky

  232. Common Sequence Variation in theVEGFAGene Predicts Risk of Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, December 2009, Association for Research in Vision and Ophthalmology (ARVO)

    Professor Nikolai Petrovsky

  233. Focus on Influenza vaccines

    Article • Human Vaccines, October 2009, Taylor & Francis

    Professor Nikolai Petrovsky

  234. P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants

    Article • Retrovirology, October 2009, Springer Science + Business Media

    Professor Nikolai Petrovsky

  235. Diabetic Retinopathy Is Associated With Elevated Serum Asymmetric and Symmetric Dimethylarginines

    Article • Diabetes Care, August 2009, American Diabetes Association

    Professor Nikolai Petrovsky

  236. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line

    Article • Nature Genetics, April 2009, Nature

    Altuna A, Piero Carninci, Professor Nikolai Petrovsky

  237. Pharmacological Management of Endocrine Conditions in the Elderly Patient

    Article • April 2009, Wiley

    Professor Nikolai Petrovsky

  238. AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5

    Article • Malaria Journal, February 2009, Springer Science + Business Media

    Professor Nikolai Petrovsky

  239. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2008, New England Journal of Medicine (NEJM/MMS)

    Professor Nikolai Petrovsky

  240. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

    Article • Diabetes Obesity and Metabolism, May 2008, Wiley

    Dr DIEGO BELLIDO, Professor Nikolai Petrovsky

  241. Antisaccade deficits in subjects either genetically or clinically at risk for schizophrenia

    Article • European Psychiatry, April 2008, Cambridge University Press

    Professor Nikolai Petrovsky

  242. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor γ agonist alleviates the symptoms of DSS-induced colitis

    Article • Biochemical and Biophysical Research Communications, March 2008, Elsevier

    Professor Nikolai Petrovsky

  243. Freeing vaccine adjuvants from dangerous immunological dogma

    Article • Expert Review of Vaccines, February 2008, Taylor & Francis

    Professor Nikolai Petrovsky

  244. Data Extraction for Improved Prediction Outcomes in Organ Transplantation — A Hybrid Approach

    Article • October 2006, World Scientific Pub Co Pte Lt

    Professor Nikolai Petrovsky

  245. Fat Aussie—A New Alström Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and Spermatogenesis

    Article • Molecular Endocrinology, July 2006, Endocrine Society

    Professor Nikolai Petrovsky

  246. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity

    Article • Vaccine, April 2006, Elsevier

    Professor Nikolai Petrovsky

  247. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice

    Article • Biochemical and Biophysical Research Communications, April 2006, Elsevier

    Professor Nikolai Petrovsky

  248. Bioinformatics for study of autoimmunity

    Article • Autoimmunity, January 2006, Taylor & Francis

    Professor Nikolai Petrovsky

  249. PREDNOD, a prediction server for peptide binding to the H-2g7haplotype of the non-obese diabetic mouse

    Article • Autoimmunity, January 2006, Taylor & Francis

    Professor Nikolai Petrovsky

  250. Type 1 Diabetes: Immunology and Genetics

    Article • January 2006, Elsevier

    Professor Nikolai Petrovsky

  251. Article • Immunome Research, January 2006, Springer Science + Business Media

    Professor Nikolai Petrovsky

  252. The Transcriptional Landscape of the Mammalian Genome

    Article • Science, September 2005, American Association for the Advancement of Science

    Piero Carninci, Professor Nikolai Petrovsky

  253. Temporal regulation of the human immune system

    Article • Expert Review of Clinical Immunology, September 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  254. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

    Article • Cardiovascular Diabetology, August 2005, Springer Science + Business Media

    Professor Nikolai Petrovsky

  255. Assessment of cardiovascular disease risk factors and diabetes mellitus in Australian prisons: is the prisoner population unhealthier than the rest of the Australian population?

    Article • Australian and New Zealand Journal of Public Health, August 2005, Elsevier

    Professor Nikolai Petrovsky

  256. Information technologies for vaccine research

    Article • Expert Review of Vaccines, June 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  257. Immunoinformatics and its relevance to understanding human immune disease

    Article • Expert Review of Clinical Immunology, May 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  258. Hypothyroidism and hyponatraemia in the hospital setting

    Article • Pathology, April 2005, Elsevier

    Professor Nikolai Petrovsky

  259. Dexamethasone Infusion Testing in the Diagnosis of Cushing's Syndrome

    Article • Endocrine Journal, January 2005, Japan Endocrine Society

    Professor Nikolai Petrovsky

  260. A Hybrid Decision Tree – Artificial Neural Networks Ensemble Approach for Kidney Transplantation Outcomes Prediction

    Article • January 2005, Springer Science + Business Media

    Professor Nikolai Petrovsky

  261. Article • Immunome Research, January 2005, Springer Science + Business Media

    Professor Nikolai Petrovsky

  262. Virtual models of the HLA class I antigen processing pathway

    Article • Methods, December 2004, Elsevier

    Professor Nikolai Petrovsky

  263. Identification of Key β Cell Gene Signaling Pathways Involved in Type 1 Diabetes

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  264. The Power of an Integrated Informatic and Molecular Approach to Type 1 Diabetes Research

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  265. Addison's disease presenting in four adolescents with type 1 diabetes

    Article • Pediatric Diabetes, December 2004, Hindawi Publishing Corporation

    Professor Nikolai Petrovsky

  266. Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications

    Article • Methods, December 2004, Elsevier

    Professor Nikolai Petrovsky

  267. Inulin‐derived adjuvants efficiently promote both Th1 and Th2 immune responses

    Article • Immunology and Cell Biology, December 2004, Wiley

    Professor Nikolai Petrovsky

  268. Elevated Lymphocyte Expression of CLIP Is Associated with Type 1 Diabetes and May Be a Useful Marker of Autoimmune Susceptibility

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  269. A rash: Part 1

    Article • Pathology, December 2004, Elsevier

    Professor Nikolai Petrovsky

  270. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

    Article • Cardiovascular Diabetology, December 2004, Springer Science + Business Media

    Professor Nikolai Petrovsky

  271. Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen

    Article • Immunology and Cell Biology, October 2004, Wiley

    Professor Nikolai Petrovsky

  272. Vaccine adjuvants: Current state and future trends

    Article • Immunology and Cell Biology, September 2004, Wiley

    Professor Nikolai Petrovsky

  273. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial

    Article • Diabetologia, August 2004, Springer Science + Business Media

    Professor Nikolai Petrovsky

  274. The perils of untimed serum cortisol measurement

    Article • Pathology, June 2004, Elsevier

    Professor Nikolai Petrovsky

  275. Identification of "pathologs" (disease-related genes) from the RIKEN mouse cDNA dataset using human curation plus FACTS, a new biological information extraction system

    Article • BMC Genomics, April 2004, Springer Science + Business Media

    Professor Nikolai Petrovsky

  276. A swollen abdomen: Part 1

    Article • Pathology, April 2004, Elsevier

    Professor Nikolai Petrovsky

  277. Systematic genome‐wide approach to positional candidate cloning for identification of novel human disease genes

    Article • Internal Medicine Journal, March 2004, Wiley

    Professor Nikolai Petrovsky

  278. VIRAL ENCEPHALITIS IN HUMANS

    Article • Immunology and Cell Biology, February 2004, Wiley

    Professor Nikolai Petrovsky

  279. Use of Artificial Neural Networks in the Prediction of Kidney Transplant Outcomes

    Article • January 2004, Springer Science + Business Media

    Professor Nikolai Petrovsky

  280. FREP: a database of functional repeats in mouse cDNAs

    Article • Nucleic Acids Research, January 2004, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  281. Autoimmune Diabetes in the NOD Mouse: An Essential Role of Fas‐FasL Signaling in β Cell Apoptosis

    Article • Annals of the New York Academy of Sciences, November 2003, Wiley

    Professor Nikolai Petrovsky

  282. Prevention of Autoimmune Diabetes through Immunostimulation with Q Fever Complement‐Fixing Antigen

    Article • Annals of the New York Academy of Sciences, November 2003, Wiley

    Professor Nikolai Petrovsky

  283. The Role of Endoplasmic Reticulum Stress in Nonimmune Diabetes: NOD.k iHEL, a Novel Model of β Cell Death

    Article • Annals of the New York Academy of Sciences, November 2003, Wiley

    Professor Nikolai Petrovsky

  284. Allergen databases

    Article • Allergy, October 2003, Wiley

    Professor Nikolai Petrovsky

  285. Computational tools for the study of allergens

    Article • Allergy, October 2003, Wiley

    Professor Nikolai Petrovsky

  286. Corrigendum

    Article • Immunology and Cell Biology, October 2003, Wiley

    Professor Nikolai Petrovsky

  287. Cytokine-Related Genes Identified From the RIKEN Full-Length Mouse cDNA Data Set

    Article • Genome Research, June 2003, Cold Spring Harbor Laboratory Press

    Piero Carninci, Professor Nikolai Petrovsky

  288. Inferring Higher Functional Information for RIKEN Mouse Full-Length cDNA Clones With FACTS

    Article • Genome Research, June 2003, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  289. Identification of Novel “Pathologs” (Human Disease-Related Gene Candidates) From the RIKEN Full-Length Mouse cDNA Data Set

    Article • Genome Research, June 2003, Cold Spring Harbor Laboratory Press

    Professor Nikolai Petrovsky

  290. Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet β Cell Expression of a Fas Ligand Transgene

    Article • The Journal of Immunology, May 2003, Oxford University Press (OUP)

    Professor Nikolai Petrovsky

  291. Bioinformatics for characterisation of allergens, allergenicity and allergic crossreactivity

    Article • Trends in Immunology, May 2003, Elsevier

    Professor Nikolai Petrovsky

  292. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter‐regulator

    Article • Immunology and Cell Biology, April 2003, Wiley

    Professor Nikolai Petrovsky

  293. Vaccine Therapies for the Prevention of Type 1 Diabetes Mellitus

    Article • Pediatric Drugs, January 2003, Springer Science + Business Media

    Professor Nikolai Petrovsky

  294. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs

    Article • Nature, December 2002, Nature

    Piero Carninci, Professor Nikolai Petrovsky

  295. Pregnancy‐associated osteoporosis with hypercalcaemia

    Article • Internal Medicine Journal, September 2002, Wiley

    Professor Nikolai Petrovsky

  296. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes

    Article • Immunology, August 2002, Wiley

    Professor Nikolai Petrovsky

  297. Computational immunology: The coming of age

    Article • Immunology and Cell Biology, June 2002, Wiley

    Professor Nikolai Petrovsky

  298. Prediction of promiscuous peptides that bind HLA class I molecules

    Article • Immunology and Cell Biology, June 2002, Wiley

    Professor Nikolai Petrovsky

  299. Response of Serum Macrophage Migration Inhibitory Factor Levels to Stimulation or Suppression of the Hypothalamo-Pituitary-Adrenal Axis in Normal Subjects and Patients with Cushing's Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Marta Korbonits, Professor Nikolai Petrovsky

  300. The Role of Fas Ligand in Beta Cell Destruction in Autoimmune Diabetes of NOD Mice

    Article • Annals of the New York Academy of Sciences, April 2002, Wiley

    Professor Nikolai Petrovsky

  301. Methods for Prediction of Peptide Binding to MHC Molecules: A Comparative Study

    Article • Extremophiles, March 2002, Springer Science + Business Media

    Professor Nikolai Petrovsky

  302. Severe diabetic retinopathy: a rare complication of acromegaly

    Article • Internal Medicine Journal, January 2002, Wiley

    Professor Nikolai Petrovsky

  303. Prospects for the Prevention and Reversal of Type 1 Diabetes Mellitus

    Article • Drugs, January 2002, Springer Science + Business Media

    Professor Nikolai Petrovsky

  304. Use of Artificial Neural Networks in Improving Renal Transplantation Outcomes

    Article • Graft, January 2002, Portico

    Professor Nikolai Petrovsky

  305. Severe diabetic retinopathy: a rare complication of acromegaly

    Article • Internal Medicine Journal, January 2002, Wiley

    Professor Nikolai Petrovsky

  306. Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding

    Article • Journal of Molecular Graphics and Modelling, October 2001, Elsevier

    Professor Nikolai Petrovsky, Prof John Zeleznikow

  307. Towards a unified model of neuroendocrine–immune interaction

    Article • Immunology and Cell Biology, August 2001, Wiley

    Professor Nikolai Petrovsky

  308. Macrophage Migration Inhibitory Factor: A Critical Neurohumoral Mediator

    Article • January 2001, Karger Publishers

    Professor Nikolai Petrovsky

  309. Molecular immunology databases and data repositories

    Article • Journal of Immunological Methods, April 2000, Elsevier

    Professor Nikolai Petrovsky, Prof John Zeleznikow

  310. Macrophage Migration Inhibitory Factor (MIF): A Critical Neurohumoral Mediator

    Article • Annals of the New York Academy of Sciences, January 2000, Wiley

    Professor Nikolai Petrovsky

  311. DIURNAL RHYTHMS OF PRO-INFLAMMATORY CYTOKINES: REGULATION BY PLASMA CORTISOL AND THERAPEUTIC IMPLICATIONS

    Article • Cytokine, April 1998, Elsevier

    Professor Nikolai Petrovsky

  312. The Chronobiology of Human Cytokine Production

    Article • International Reviews of Immunology, January 1998, Taylor & Francis

    Professor Nikolai Petrovsky

  313. Danazol in the treatment of a systemic lupus erythematosus (SLE)‐like illness associated with deficiency of the fourth component of complement

    Article • Australian and New Zealand Journal of Medicine, April 1997, Wiley

    Professor Nikolai Petrovsky

  314. HLA Class II-associated polymorphism of interferon-γ production implications for HLA-disease association

    Article • Human Immunology, March 1997, Elsevier

    Professor Nikolai Petrovsky

  315. Evidence for the Viral Aetiology of IDDM

    Article • Autoimmunity, January 1997, Taylor & Francis

    Professor Nikolai Petrovsky

  316. A strategy for prediction of peptide binding affinity for the human peptide transporter

    Article • Human Immunology, April 1996, Elsevier

    Professor Nikolai Petrovsky

  317. The paradoxical association between immunodeficiency and autoimmunity: Comment on he article by Atkinson

    Article • Arthritis & Rheumatism, January 1996, Wiley

    Professor Nikolai Petrovsky

  318. Th1 and Th2: swinging to a hormonal rhythm

    Article • Immunology Today, December 1995, Elsevier

    Professor Nikolai Petrovsky

  319. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells

    Article • Journal of Immunological Methods, October 1995, Elsevier

    Professor Nikolai Petrovsky

  320. T-cell receptor signal sequences

    Article • Immunology Today, August 1995, Elsevier

    Professor Nikolai Petrovsky

  321. HLA-matched control subjects are essential in studies of susceptibility to IDDM

    Article • Diabetologia, January 1995, Springer Science + Business Media

    Professor Nikolai Petrovsky

  322. Difficulties and dangers of vaccination strategies for asthma and other autoimmune disorders

    Article • The Lancet, October 1994, Elsevier

    Professor Nikolai Petrovsky

  323. Whole Blood Assays and the Influence of Circadian Rhythmicity on Human Cytokine Measurement

    Article • Springer Science + Business Media

    Professor Nikolai Petrovsky

  324. Immunoinformatics—The New Kid in Town

    Article • Wiley

    Professor Nikolai Petrovsky

  325. Use of Artificial Neural Networks in Improving Renal Transplantation Outcomes

    Article • Graft, Portico

    Professor Nikolai Petrovsky

  326. The Future for Computational Modelling and Prediction Systems in Clinical Immunology

    Article • Wiley

    Professor Nikolai Petrovsky